Received Apr 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | IM |
the diabetes was diagnosed after the covid vaccine; This spontaneous case was reported by a patient and describes the occurrence of DIABETES MELLITUS (the diabetes was diagnosed after the covid vaccine) in a 77-year-old male patient who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. Concurrent medical conditions included Ulcerative colitis. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced DIABETES MELLITUS (the diabetes was diagnosed after the covid vaccine) (seriousness criterion medically significant). At the time of the report, DIABETES MELLITUS (the diabetes was diagnosed after the covid vaccine) outcome was unknown. The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) was unknown. No concomitant medications were reported. It was unknown if the patient experienced any additional symptoms/events. Reporter causality was not reported. No treatment medications were reported. Reporter did not allow further contact; Reporter's Comments: The benefit -risk relationship of product is not affected by this report.
Ulcerative colitis